There appears to be an association between FTD and length polymorphism in the gene promotor S(5-HTTLPR) of the serotonin transporter gene (SLC6A4) which suggests serotonin may be involved in the pathogenesis of FTD. The gene discussed is SLC6A4; the disease is frontotemporal dementia.